Category:Resources: Difference between revisions

From Guide to YKHC Medical Practices

No edit summary
Line 1: Line 1:
== References ==
== References ==
*[[media:Antibiogram.pdf|Antibiogram 2017]] (links to pdf).
*[[media:Antibiogram.pdf|Antibiogram 2018]] (links to pdf).
This latest version of the YKHC antibiogram is easier to read, in color, and on one page thanks to Thaddus Wilkerson, PharmD. Keep up the good work in prescribing.  Our MRSA rate is the lowest in years. Also note we have added Cefipime which is becoming a preferred agent for empiric MDRO treatment as it is safer for the kidneys than zosyn when used in combination wih vancomycin.  Also a big thanks to Melanie McIntyre in the lab who keeps track of all this data for us.  
This latest version of the YKHC antibiogram is easier to read, in color, and on one page thanks to Thaddus Wilkerson, PharmD. Keep up the good work in prescribing.  Our MRSA rate is the lowest in years. Also note we have added Cefipime which is becoming a preferred agent for empiric MDRO treatment as it is safer for the kidneys than zosyn when used in combination wih vancomycin.  Also a big thanks to Melanie McIntyre in the lab who keeps track of all this data for us.  
*[[CME Process]]
*[[CME Process]]

Revision as of 20:07, 29 April 2019

References

This latest version of the YKHC antibiogram is easier to read, in color, and on one page thanks to Thaddus Wilkerson, PharmD. Keep up the good work in prescribing. Our MRSA rate is the lowest in years. Also note we have added Cefipime which is becoming a preferred agent for empiric MDRO treatment as it is safer for the kidneys than zosyn when used in combination wih vancomycin. Also a big thanks to Melanie McIntyre in the lab who keeps track of all this data for us.

AMION Scheduling App Login

This category currently contains no pages or media.